BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35718188)

  • 1. The mechanism by which crocetin regulates the lncRNA NEAT1/miR-125b-5p/SOX7 molecular axis to inhibit high glucose-induced diabetic retinopathy.
    Chen Q; Xi X; Ma J; Wang X; Xia Y; Wang X; Deng Y; Li Y
    Exp Eye Res; 2022 Sep; 222():109157. PubMed ID: 35718188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
    Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
    [No Abstract]   [Full Text] [Related]  

  • 3. MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axis.
    Cao X; Xue LD; Di Y; Li T; Tian YJ; Song Y
    Life Sci; 2021 May; 272():119232. PubMed ID: 33600866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis.
    Tan A; Li T; Ruan L; Yang J; Luo Y; Li L; Wu X
    Exp Eye Res; 2021 Jun; 207():108585. PubMed ID: 33887222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of miR-192-5p inhibits the ELAVL1/PI3Kδ axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy.
    Fu XL; He FT; Li MH; Fu CY; Chen JZ
    Diabet Med; 2023 Sep; 40(9):e15077. PubMed ID: 36861382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy.
    Wang JJ; Wu KF; Wang DD
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1175-1183. PubMed ID: 34081870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro protective effect of miR-181d-5p in high glucose‑induced human retinal microvascular endothelial cells by targeting the angiogenic factor VEGFA.
    Wang F; Yu C
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6199-6207. PubMed ID: 36111920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG1 targets miR-340-5p/PIK3CA axis to regulate microvascular endothelial cell proliferation, migration, and angiogenesis in DR.
    He FT; Fu XL; Li MH; Fu CY; Chen JZ
    Kaohsiung J Med Sci; 2023 Jan; 39(1):16-25. PubMed ID: 36484399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA THRIL promotes high glucose-induced proliferation and migration of human retina microvascular endothelial cells through enhancing autophagy.
    Ji Q; Han J; Liu J; Lv H; Wang L; Dong Y; Shi L
    Acta Diabetol; 2022 Mar; 59(3):369-380. PubMed ID: 34718852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-coding RNA SPAG5-AS1 Attenuates Diabetic Retinal Vascular Dysfunction by Inhibiting Human Retinal Microvascular Endothelial Cell Proliferation, Migration, and Tube Formation by Regulating the MicroRNA-1224-5p/IRS-1 Axis.
    Su X; Yang X; Liu H
    Mol Biotechnol; 2023 Jun; 65(6):904-912. PubMed ID: 36346578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin inhibits angiogenesis in retinal microvascular endothelial cells through regulating of the miR-140-5p/HDAC3-mediated PTEN/PI3K/AKT pathway.
    Fu C; Peng J; Ling Y; Zhao H; Zhao Y; Zhang X; Ai M; Peng Q; Qin Y
    BMC Ophthalmol; 2023 Jul; 23(1):302. PubMed ID: 37415101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.
    Yu L; Fu J; Yu N; Wu Y; Han N
    Can J Physiol Pharmacol; 2020 Apr; 98(4):219-227. PubMed ID: 31689123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1 aggravates the retinal angiogenesis via miR-320a/HIF-1α axis in diabetic retinopathy.
    Chen Z; Yang J; Gao Y; Jiang S; Li Z; Wang Y; Hu Z; Han F; Ni N
    Exp Eye Res; 2022 May; 218():108984. PubMed ID: 35202706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA NEAT1 facilitates survival and angiogenesis in oxygen-glucose deprivation (OGD)-induced brain microvascular endothelial cells (BMECs) via targeting miR-377 and upregulating SIRT1, VEGFA, and BCL-XL.
    Zhou ZW; Zheng LJ; Ren X; Li AP; Zhou WS
    Brain Res; 2019 Mar; 1707():90-98. PubMed ID: 30408478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. linc00174 deteriorates the pathogenesis of diabetic retinopathy via miR-26a-5p/PTEN/Akt signalling cascade-mediated pyroptosis.
    Wang JJ; Chen ZL; Wang DD; Wu KF; Huang WB; Zhang LQ
    Biochem Biophys Res Commun; 2022 Nov; 630():92-100. PubMed ID: 36152350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA TUG1 alleviates diabetic retinal vascular dysfunction through regulating miR-524-5p/FGFR2.
    Tian M; Yang J; Yan X; Cao Y; Liu Y; Lei Y; Lv H
    Bioengineered; 2022 May; 13(5):12661-12672. PubMed ID: 35599572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MEG3 inhibits neovascularization in diabetic retinopathy by regulating microRNA miR-6720-5p and cytochrome B5 reductase 2.
    Chen J; Liao L; Xu H; Zhang Z; Zhang J
    Bioengineered; 2021 Dec; 12(2):11872-11884. PubMed ID: 34978518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA XIST promotes neovascularization in diabetic retinopathy by regulating miR-101-3p/VEGFA.
    Fu W; Ye Y; Hu F
    Arch Endocrinol Metab; 2024 May; 68():e230097. PubMed ID: 38739522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NEAT1 Accelerates the Proliferation, Oxidative Stress, Inflammation, and Fibrosis and Suppresses the Apoptosis Through the miR-423-5p/GLIPR2 Axis in Diabetic Nephropathy.
    Wu X; Fan D; Chen B
    J Cardiovasc Pharmacol; 2022 Mar; 79(3):342-354. PubMed ID: 34803150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.